Get in touch with Mark

Submit

Thank you

About Mark

Mark is a UK patent and design attorney and European patent attorney with a technical background in high energy physics. In 2012, Mark began his PhD in Physics at the University of Birmingham where he was part of the particle physics group. He studied the properties of top-antitop quarks produced at the Large Hadron Collider. As part of his research program, Mark worked at CERN in Geneva for 15 months, assisting in the operation of the ATLAS experiment, before completing his PhD in 2016. Mark previously studied Mathematics and Physics at the University of Warwick, where he graduated with a first class Masters degree in 2009.

Mark joined Keltie in 2016. Previously, Mark spent 30 months working at KPMG as an audit assistant. His clients included a number of national and multinational firms. Since joining Keltie, Mark has worked extensively in the field of software, with experience in the drafting and prosecution of patent applications relating to management systems, fintech, and computer-generated animation. Mark has additionally worked on patent applications relating to a variety of other fields including the automotive industry and amusement parks.

 

Mark qualified as a European Patent Attorney in 2021 and as a UK Patent Attorney in 2023.

More
Crowdfunding

25.11.2021

Crowdfunding

Crowdfunding is an increasingly popular method for a company to raise funds to get a new product off the ground. This is particularly prevalent for small businesses and start-ups within the lifestyle and wellness sectors. Successful crowdfunding has been seen in diverse areas such as tabletop gaming, comic books and virtual reality headsets. The potential for a company with its roots in crowdfunding can be extremely high, with the company Oculus starting from searching for a $250,000 investment on Kickstarter to eventually being bought out by Facebook for a figure in the billions.

More
CRISPR patent battle update

06.08.2024

CRISPR patent battle update

Last year, we published an article looking at some of the IP issues raised by CRISPR-Cas9 gene-editing technology. One of these issues concerned the battles over the ownership of certain fundamental patents.

Get in touch with Mark

Submit

Thank you